Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 for Nitrogen Retention: Dosing and Timeline Comparison

Below is a structured comparison of dosing protocols, nitrogen retention outcomes, and timeline expectations based on published clinical trial data. 12.5mg Healthy elderly (65+) +0.3 to +0.5 4–6 weeks Modest retention; minimal side effects; well-tolerated long

This comparison does not assign a generated winner or score.

  • Below is a structured comparison of dosing protocols, nitrogen retention outcomes, and timeline expectations based on published clinical trial data.
  • 12.5mg
  • Healthy elderly (65+)
  • +0.3 to +0.5
  • 4–6 weeks
  • Modest retention; minimal side effects; well-tolerated long-term
  • 25mg
  • +0.7 to +1.2
  • 2–3 weeks
  • Standard research dose; consistent retention; transient edema common
  • Obese adults (caloric deficit)
  • +0.6 to +0.9
  • 3–4 weeks
  • Preserved lean mass during fat loss; appetite stimulation may complicate adherence
  • Post-surgical recovery
  • +0.5 to +1.0
  • 7–10 days
  • Blunted catabolic response; faster return to neutral nitrogen balance
  • 50mg
  • Healthy young adults
  • +0.8 to +1.3
  • No additional retention vs 25mg; higher incidence of glucose intolerance and water retention
  • The comparison makes clear that 25mg daily is the optimal research dose for nitrogen retention across most populations. Higher doses don't produce proportionally greater retention and increase metabolic side effects, while lower doses take longer to reach measurable endpoints.
More references

Related material